Synonym: (5α,6β)-17-(Cyclopropylmethyl)-4,5-epoxy-morphinan-3,6,14-triol hydrate
CAS Number: 1034528-53-4
Empirical Formula (Hill Notation): C20H25NO4 · xH2O
Molecular Weight: 343.42 (anhydrous basis)
MDL Number: MFCD08277038
Linear Formula: C20H25NO4 · xH2O
Product Type: Chemical
This picture is provided solely for illustration purposes, it may have been created or edited with AI. Optical properties of the actual product may deviate. Relevant product information is printed on labeled products and other accompanying or available information material.
This image depicts N9412-50MG.
| assay |
≥96% (HPLC) |
| color |
white |
| drug control |
regulated under CDSA - not available from Sigma-Aldrich Canada |
| form |
powder |
| InChI |
1S/C20H25NO4.H2O/c22-13-4-3-12-9-15-20(24)6-5-14(23)18-19(20,16(12)17(13)25-18)7-8-21(15)10-11-1-2-11;/h3-4,11,14-15,18,22-24H,1-2,5-10H2;1H2/t14-,15-,18+,19+,20-;/m1./s1 |
| InChI key |
VHGGWFVHXKTOPK-CDHBEYIESA-N |
| Quality Level |
100  |
| SMILES string |
[H]O[H].O[C@@H]1CC[C@@]2(O)[C@H]3Cc4ccc(O)c5O[C@@H]1[C@]2(CCN3CC6CC6)c45 |
| solubility |
DMSO: ~12 mg/mL |
| |
H2O: insoluble |
| storage temp. |
2-8°C |
| Biochem/physiol Actions: |
Neutral antagonist of the μ-opioid receptor. A reduction of withdrawal effects associated with neutral μ-opioid receptor antagonists may offer advantages in treating opioid overdose and addiction. |
| Features and Benefits: |
This compound is featured on the Opioid Receptors page of the Handbook of Receptor Classification and Signal Transduction. To browse other handbook pages, click here . |
| Packaging: |
10, 50 mg in glass bottle |
| RIDADR |
NONH for all modes of transport |
| WGK Germany |
WGK 3 |
| Flash Point(F) |
Not applicable |
| Flash Point(C) |
Not applicable |
| Purity |
≥96% (HPLC) |
| Storage Temp. |
2-8°C |
| UNSPSC |
12352200 |